HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Yin Selected Research

Deoxycytidine Kinase

1/2021Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Yin Research Topics

Disease

21Glioma (Gliomas)
09/2020 - 06/2008
20Neoplasms (Cancer)
02/2024 - 06/2007
9Infections
12/2023 - 11/2014
9Inflammation (Inflammations)
10/2023 - 01/2017
9Stomach Neoplasms (Stomach Cancer)
12/2022 - 10/2013
5Leukemia
01/2021 - 07/2007
3Chronic Obstructive Pulmonary Disease (COPD)
07/2022 - 11/2014
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 05/2006
3Carcinogenesis
05/2017 - 01/2009
2Candidiasis (Moniliasis)
01/2024 - 01/2024
2COVID-19
01/2024 - 01/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 09/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 11/2019
2Burns
01/2022 - 09/2017
2Keloid
01/2022 - 01/2022
2Adenocarcinoma of Lung
01/2020 - 02/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 03/2012
2Virus Diseases (Viral Diseases)
01/2018 - 12/2016
2Colorectal Neoplasms (Colorectal Cancer)
05/2017 - 08/2012
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2017 - 08/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 01/2015
2Diabetes Mellitus
11/2014 - 10/2013
2Ascites
12/2013 - 10/2013
2Diabetes Complications
12/2013 - 10/2013
2Alzheimer Disease (Alzheimer's Disease)
03/2012 - 06/2010
1Ovarian Neoplasms (Ovarian Cancer)
04/2024
1Rupture
03/2024
1Genomic Instability
02/2024
1Peripheral Nervous System Diseases (PNS Diseases)
02/2024
1Congenital Abnormalities (Deformity)
02/2024
1Autoimmune Diseases (Autoimmune Disease)
01/2024
1Mycoses (Diseases, Fungus)
01/2024
1Candidemia
01/2024
1Disease Resistance
10/2023
1Zika Virus Infection
04/2023
1Bacterial Infections (Bacterial Infection)
01/2023

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2005
11Messenger RNA (mRNA)IBA
01/2022 - 06/2008
10MicroRNAs (MicroRNA)IBA
01/2022 - 06/2008
6RNA (Ribonucleic Acid)IBA
09/2020 - 07/2009
5Transcription Factors (Transcription Factor)IBA
01/2017 - 09/2012
4Interleukin-17 (Interleukin 17)IBA
01/2024 - 08/2016
4CytokinesIBA
10/2023 - 08/2016
4Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2019
4Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2012
3endostar proteinIBA
01/2023 - 09/2021
3RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 05/2013
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 05/2006
33' Untranslated Regions (3' UTR)IBA
09/2018 - 11/2012
3InterferonsIBA
05/2017 - 01/2011
3NectinsIBA
06/2010 - 05/2005
2Histone Deacetylases (Histone Deacetylase)IBA
02/2024 - 07/2009
2Interleukin-6 (Interleukin 6)IBA
01/2024 - 08/2016
2InterleukinsIBA
01/2024 - 05/2017
2LipopolysaccharidesIBA
01/2023 - 07/2015
2Small Interfering RNA (siRNA)IBA
01/2022 - 05/2017
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 09/2017
2Polypyrimidine Tract-Binding ProteinIBA
02/2019 - 05/2017
2AcidsIBA
01/2018 - 06/2016
2Antimicrobial PeptidesIBA
01/2018 - 01/2017
2Protein Isoforms (Isoforms)IBA
05/2017 - 11/2015
2Imiquimod (Aldara)FDA LinkGeneric
05/2017 - 08/2016
2GemcitabineFDA Link
01/2016 - 01/2015
2Hemoglobins (Hemoglobin)IBA
12/2013 - 10/2013
2AlbuminsIBA
12/2013 - 10/2013
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
09/2012 - 01/2012
1CateninsIBA
04/2024
1NickelIBA
03/2024
1Phosphotransferases (Kinase)IBA
02/2024
1Tyrosine (L-Tyrosine)FDA Link
02/2024
1rilonaceptFDA Link
01/2024
1Interleukin-4 (Interleukin 4)IBA
01/2024
1tocilizumab (atlizumab)FDA Link
01/2024
1Interleukin-1 (Interleukin 1)IBA
01/2024
1Antifungal AgentsIBA
01/2024
1bimekizumabIBA
01/2024
1Interleukin-2 (IL2)IBA
01/2024
1Interleukin-23 (Interleukin 23)IBA
01/2024
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2024
1dupilumabIBA
01/2024
1brodalumabIBA
01/2024
1Interleukin InhibitorsIBA
01/2024
1secukinumabIBA
01/2024
1Daclizumab (Zenapax)FDA Link
01/2024
1ixekizumabIBA
01/2024
1BasiliximabFDA Link
01/2024
1canakinumabFDA Link
01/2024
1Caspase 1 (ICE Protease)IBA
12/2023
1SaponinsIBA
10/2023
1RNA Splicing FactorsIBA
04/2023
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2023

Therapy/Procedure

9Therapeutics
04/2024 - 01/2015
7Gastrectomy
10/2019 - 10/2013
3Drug Therapy (Chemotherapy)
02/2022 - 05/2006
3Blood Transfusion (Blood Transfusions)
10/2019 - 03/2014
2Injections
02/2022 - 09/2021
2Subcutaneous Injections
01/2022 - 05/2019
2Critical Care (Surgical Intensive Care)
07/2018 - 11/2014
2Length of Stay
11/2014 - 10/2013
1Duration of Therapy
01/2024